Relationship between MDR1 gene polymorphism and blood concentration of tacrolimus in renal transplant patients

National Medical Journal of China

Volumn 85, Issue 46, 2005, Pages 3277-3281

  Wang, Wei ^a   Zhang, Xiao Dong ^a   Ma, Lin Lin ^a   Lü, Yue Ping ^a   Hu, Xiao Peng ^a   Zhang, Peng ^a   Wang, Yong ^a   Guan, De Lin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Drug resistance, multiple; Kidney transplantation; P glycoprotein; Polymorphism, single nucleotide; Tacrolimus

Indexed keywords

AZATHIOPRINE; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA CONTENT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TACROLIMUS;

EID: 31744449745     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet, 1995, 29: 404-430.
2. Chen C, Clark D, Ueda K, et al. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. J Biol Chem, 1990, 265: 506-514.
3. Benet LT, Izumi T, Zhang Y, et al. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. J Control Release, 1999, 62: 25-31.
4. Kim RB, Leake BF, Choo EF, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther, 2001, 70: 189-199.
5. Cascorbi I, Gerloff T, Johne A, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther, 2001, 69: 168-174.
6. Arceci RJ. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood, 1993, 81: 2215-2222.
7. Feng YM, Hao XS, Mao HS, et al. Clinical significance of MDR gene expression in malignant pleural effusion and ascites and solid tumors. Natl Med J China, 2001, 81: 1484-1487.
8. Van Helvoort A, Smith AJ, Sprong H, et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell, 1996, 87: 507-517.
9. Cooper DN, Smith BA, Cooke HJ, et al. An estimate of unique DNA sequence heterozygosity in the human genome. Hum Genet, 1985, 69: 201-205.
10. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA, 2000, 97: 3473-3478.
11. Balram C, Sharma A, Sivathasan C, et al. Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asian population: phenotypic-genotypic correlates. J Clin Pharmacol, 2003, 56: 78-83.
12. Tanabe M, Ieiri I, Nagata N, et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther, 2001, 297: 1137-1143.
13. Horinouchi M, Sakaeda T, Nakamura T, et al. Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin. Pharm Res, 2002, 19: 1581-1585.
14. Mai I, Perloff ES, Bauer S, et al. MDR1 haplotypes derived from exons 21 and 26 do not affect the steady-state pharmacokinetics of tacrolimus in renal transplant patients. Br J Clin Pharmacol, 2004, 58: 548-553.
15. Anglicheau D, Thervet E, Etienne I, et al. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther, 2004, 75: 422-433.